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Abstract: To identify proteins that cooperate with cellular communication network factor 2 (CCN2),
we carried out GAL4-based yeast two-hybrid screening using a cDNA library derived from the
chondrocytic cell line HCS-2/8. Rab14 GTPase (Rab14) polypeptide was selected as a CCN2-interactive
protein. The interaction between CCN2 and Rab14 in HCS-2/8 cells was confirmed using the in situ
proximity ligation assay. We also found that CCN2 interacted with Rab14 through its IGFBP-like
domain among the four domains in CCN2 protein. To detect the colocalization between CCN2
and Rab14 in the cells in detail, CCN2, wild-type Rab14 (Rab14WT), a constitutive active form
(Rab14CA), and a dominant negative form (Rab14DN) of Rab14 were overexpressed in monkey
kidney-tissue derived COS7 cells. Ectopically overexpressed Rab14 showed a diffuse cytosolic
distribution in COS7 cells; however, when Rab14WT was overexpressed with CCN2, the Rab14WT
distribution changed to dots that were evenly distributed within the cytosol, and both Rab14 and
CCN2 showed clear colocalization. When Rab14CA was overexpressed with CCN2, Rab14CA and
CCN2 also showed good localization as dots, but their distribution was more widespread within
cytosol. The coexpression of Rab14DN and CCN2 also showed a dotted codistribution but was
more concentrated in the perinuclear area. Quantitative reverse transcription polymerase chain
reaction (qRT-PCR) analysis revealed that the reduction in RAB14 or CCN2 mRNA by their respective
siRNA significantly enhanced the expression of ER stress markers, BIP and CHOP mRNA in HCS-2/8
chondrocytic cells, suggesting that ER and Golgi stress were induced by the inhibition of membrane
vesicle transfer via the suppression of CCN2 or Rab14. Moreover, to study the effect of the interaction
between CCN2 and its interactive protein Rab14 on proteoglycan synthesis, we overexpressed
Rab14WT or Rab14CA or Rab14DN in HCS-2/8 cells and found that the overexpression of Rab14DN
decreased the extracellular proteoglycan accumulation more than the overexpression of Rab14WT/CA
did in the chondrocytic cells. These results suggest that intracellular CCN2 is associated with Rab14
on proteoglycan-containing vesicles during their transport from the Golgi apparatus to endosomes in
chondrocytes and that this association may play a role in proteoglycan secretion by chondrocytes.
Keywords: cellular communication network factor 2; CCN2; CTGF; Rab14; yeast two-hybrid;
chondrocyte; ER stress; aggrecan
1. Introduction
Cellular communication network factor 2/CCN family 2 (CCN2)/connective tissue growth factor
(CTGF) is expressed in various types of cells, such as vascular endothelial cells, chondrocytes,
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and osteoblasts [1–6]. CCN2 regulates the cell proliferation, adhesion, migration, and differentiation
of various types of cells, including the above cells, and is strongly expressed in growth plate
cartilage, especially in (pre)-hypertrophic chondrocytes, enhancing bone formation through cartilage
development [1,3,6]. CCN2 has multiple cellular functions, such as chondrocyte proliferation,
the stimulation of the cartilage-specific extracellular matrix (ECM) synthesis, as well as chondrocyte
maturation [1]. The importance of CCN2 in bone formation has also been demonstrated in Ccn2 null
mutant mice, which die within minutes after birth due to respiratory failure resulting from immature
bone formation [7]; this indicates the essential role of CCN2 in chondrocytes.
CCN2 protein is composed of four characteristic modules of IGFBP-like (insulin-like growth
factor binding protein-like), VWC (von Willebrand factor type C), TSP-1 (thrombospondin type 1)
repeats, and CT (C-terminal cystine knot), and each domain has multiple interactive proteins by which
CCN2 modulates the activity of these binding partners [1]. We previously reported that CCN2 binds
to extracellular proteins, such as fibronectin through the CT domain [8] and aggrecan through the
N-terminal half [9], and CCN2 also binds to CCN3 and CCN2 itself and modulates the activity each
other [10].
There have also been reports suggesting that CCN5 may perform regulatory activities by acting
as a transcriptional factor [11], and those interactions may play important roles in cellular functions.
To identify additional intracellular, extracellular, or cell surface targets for CCN2 that may be regulated
in the functions of CCN2 in chondrocytes, we searched for CCN2-binding proteins using the yeast
two-hybrid screening system from a cDNA library derived from HCS-2/8, a human chondrocytic cell
line [12]. We identified Ras-related protein (Rab) 14 GTPase as a new interactive protein of CCN2,
suggesting that CCN2 may also exert intracellular functions by interacting to intracellular proteins.
Rab proteins belong to the low-molecular-weight GTPase superfamily and are involved in
intracellular membrane trafficking [13]. These proteins are inactive when bound to GDP, but when the
molecular switches are ON, they bind to GTP and change to the active form. Activated Rab proteins
recruit “effector proteins” to the vesicle membrane and promote membrane trafficking. Different Rab
proteins are localized to specific intracellular membranes, where they function as regulators of distinct
steps in membrane traffic pathways [14]. Rab14 in particular is involved in membrane trafficking
between the Golgi complex and endosomes and regulates apical targeting in polarized epithelial
cells [15]. KIF16B reportedly associates directly with the Rab14 on FGF receptor containing vesicles
and transports them toward the plasma membrane [16]. However, while the expression and function
of Rab family small GTPases have been clarified using various types of cells, there has been only one
report on the expression and function of Rab proteins in chondrocytes, which showed that Rab23
regulates chondrocyte differentiation in embryonal carcinoma-derived chondrogenic cell line, ATDC5
cells [17]. There have been no reports on Rab14 in chondrocytes.
There seems to be some functional interplay between CCN2 and Rab14; however, the functional
and physiological interaction between these two proteins has not been explored. In the present study,
we show for the first time that CCN2 interacts to Rab14 through its IGFBP-like domain among the
four domains in CCN2 and indicate that CCN2 and Rab14 are colocalized in the cells and regulate
intracellular membrane trafficking. We also found that endoplasmic reticulum (ER) and Golgi stresses
were increased by suppressing the expression of mRNA of CCN2 and Rab14, resulted in the failure of
the trafficking of aggrecan-containing vesicles from the Golgi apparatus.
2. Results
2.1. The Gene Expression of Rab14 and Ccn2 in Mouse Tissues
We examined the expression of Rab14 and Ccn2 mRNA in various tissues from four-day-old mice
by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Although the expression
of Rab14 mRNA was high in the brain, kidney, liver, spleen, and calvaria bone, the mRNA was also
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observed in the rib cartilage, heart, and muscle (Figure 1A). Ccn2 mRNA was strongly expressed in
bone and cartilage (Figure 1B).
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expressed in AH109 yeast cells as a GAL4-transactivation domain (GAL4-AD)-fusion protein, while 
the full-length and individual domains of CCN2 were coexpressed as GAL4-DNA binding domain 
(GAL4-BD)-fusion protein. The interaction between each CCN2 fragment and Rab14 led to the 
transcriptional activation of the GAL4 responsive promoter, and the promoter activity was monitored 
using independent reporter genes, such as histidine and adenine synthetase. As a result, only 
transformants viable on synthetically defined medium lacking histidine and adenine, respectively, 
were grown and visualized. Interaction with Rab14 was strongly observed after co-transformation 
with full-length CCN2 as well as a fragment containing the IGFBP-like domain (Figure 2A). 
To confirm the interaction between CCN2 and Rab14 in chondrocytes, we next performed the in 
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interest were recognized by two primary antibodies raised in different species. When the secondary 
antibodies called PLA probes were in close proximity, the protein interactions were visualized in 
fixed cells. As a result, we detected positive signals in the chondrocytic cells by using the combination 
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Figure 1. The gene expression of Rab14 and Ccn2 in mouse tissues. The expression of Rab14 (A) and
Ccn2 (B) mRNA in the calvaria, brain, cartilage, heart, kidney, liver, muscle, and spleen tissues of
four-day-old mice monitored by qRT-PCR. The level of each mRNA was standardized to that of Gapdh
mRNA. The data are presented as the mean ± SD of triplicate samples.
2.2. Rab14 Interacts with the IGFBP-like Domain of CCN2
Searching for CCN2 interactive proteins by yeast two-hybrid screening, we identified several
clones from a human chondrocytic cell (HCS-2/8 cell) cDNA library that encoded Rab14, showing it to
be an interactive protein of CCN2. To identify the interaction domains in CCN2, Rab14 was expressed
in AH109 yeast cells as a GAL4-transactivation domain (GAL4-AD)-fusion protein, while the full-length
and individual domains of CCN2 were coexpressed as GAL4-DNA binding domain (GAL4-BD)-fusion
protein. The interaction between each CCN2 fragment and Rab14 led to the transcriptional activation of
the GAL4 responsive promoter, and the promoter activity was monitored using independent reporter
genes, such as histidine and adenine synthetase. As a result, only transformants viable on synthetically
defined medium lacking histidine and adenine, respectively, were grown and visualized. Interaction
with Rab14 was strongly observed after co-transformation with full-length CCN2 as well as a fragment
containing the IGFBP-like domain (Figure 2A).
To confirm the interaction between CCN2 and Rab14 in chondrocytes, we next performed the in
situ proximity ligation assay (PLA) using chondrocytic HCS-2/8 cells. In PLA, the target proteins of
interest were recognized by two primary antibodies raised in different species. When the secondary
antibodies called PLA probes were in close proximity, the protein interactions were visualized in fixed
cells. As a result, we detected positive signals in the chondrocytic cells by using the combination of
anti-CCN2 antibody (α-CCN2) and anti-RAB14 antibody (α-RAB14), and we hardly detected signals
without these primary antibodies (Figure 2B). These results indicate that CCN2 and Rab14 interact in
the chondrocyte, and the IGFBP-like domain contributed to the interaction between them.
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Figure 2. cel ular communication etwork factor 2 (CCN2) interac ion domain with Rab14 GTPase
(Rab14). Full-length CCN2 and its subdomains were exp ssed in the yeast cells as GAL4-BD fusion
proteins, and full-length Rab14 was co-expressed as transcriptional activation domain fusio protein.
The promote activity induced by the interact on of both was monitored using independent reporter
genes, such as histidine an adenine sy th tase. Only transformants viable on synthetically defined
medium lacking hist dine an adenine w re grown and visu lized (mock: pGBKT7 or pGADT7
empty plasmid) (A). The interaction b tween CCN2 a d Rab14 in HCS-2/8 cells was assessed by
proximity ligation assay (PLA) technology (red, see result 2.2). Nuclei were visualiz d by DAPI (blue).
Abbreviations: Ab (+), u ing α-CCN2 and α-RAB14 as primary antibodies; Ab (-), without primary
antibody (negative control) (B).
2.3. Association of Intracellular CCN2 with Rab14 on Vesicles During Their Transport in Cells
To confirm the interaction between CCN2 and Rab14 in living cells, we overexpressed green
fluorescent protein (GFP)-fused CCN2 and Halo-fused Rab14 wild-type (Rab14WT) or Rab14 mutants
ectopically. We first examined the expression of CCN2 and Rab14 in HCS-2/8, COS7 and MDA-MB-231
cells [18] by qRT-PCR and Western Blotting because we needed to know which cell line is suitable
for this experiment. The basal levels of Rab14 expression did not vary remarkably among these
cell lines. In contrast, the relative CCN2 expression in HCS-2/8 cells was 1.5- and 10-fold higher
than MDA-MB-231 with a high ability of aggrecan production [18] and COS7 cells, respectively
(Figure 3A–C). Preliminary experiment revealed that the strong positive expression of endogenous
CCN2 masked the behavior of ectopic Rab14 in the cell. Therefore, to avoid such masking effect by
endogenous CCN2, we selected COS7 cells that only slightly expressed and produced CCN2.
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confirmed by Western blotting (D). COS7 cells were cotransfected with GFP-fused CCN2 and Halo-
fused Rab14WT or Rab14 mutants. GFP-fused proteins (green) and Halo-fused proteins (red) were 
overexpressed together and directly monitored by fluorescence microscopy. The counterstaining of 
nuclei was performed with DAPI (blue), and these images were merged using a software program. 
Without CCN2-coexpression, Halo-tag or Rab14WT showed cytosolic distribution (E). Halo-tagged 
Rab14WT was overexpressed with GFP-fused CCN2 (F). Rab14CA was overexpressed with CCN2 
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Figure 3. C N2 and Rab14 expressi i / , S7, and MDA-MB-231 cell lines, and molecular
imaging of CCN2 and Rab14 ectopically over xpressed in COS7 cells. The xpression level of C N2 and
Rab14 in the cell lines was analyzed by qRT-PCR and Western Blotting (A–C). All cells were incubated
under standard culture conditions (20% O2, 5% CO2, and 37 ◦C). The expression of GFP-fused CCN2,
Halo-fused Rab14WT, Rab14 CA and Rab14DN proteins in the COS7 cell were confirmed by Western
blotting (D). COS7 cells were cotransfected with GFP-fused CCN2 and Halo-fused Rab14WT or Rab14
mutants. GFP-fused proteins (green) and Halo-fused proteins (red) were overexpressed together and
directly monitored by fluorescence microscopy. The counterstaining of nuclei was performed with
DAPI (blue), and these images were merged using a software program. Without CCN2-coexpression,
Halo-tag or Rab14WT showed cytosolic distribution (E). Halo-tagged Rab14WT was overexpressed with
GFP-fused CCN2 (F). Rab14CA was overexpressed with CCN2 (G), and Rab14DN was overexpressed
with CCN2 (H). Similar results were obtained in different examinations. Scale bar: 20 µm.
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Next, we confirmed proper expressions of GFP-fused CCN2 and Halo-fused Rab14 proteins in
the COS7 cells by Western Blotting (Figure 3D). Without GFP-fused CCN2 coexpression, Halo-fused
Rab14 showed diffused cytosolic distribution (Figure 3E). However, when Halo-fused Rab14WT
was overexpressed with GFP-fused CCN2, the Rab14 distribution changed to dots that were evenly
distributed within the cytosol, and Rab14 and CCN2 showed complete colocalization (Figure 3F).
Previous studies showed that the overexpression of the constitutive active mutant
Rab14Q70L promoted membrane trafficking between the Golgi complex and endosomes.
Conversely, the overexpression of Rab14 dominant negative mutants Rab14S25N prevented such vesicle
trafficking [15]. Therefore, we used these mutants to investigate the association between Rab14 and
CCN2. When the constitutive active form Rab14Q70L (Rab14CA) was overexpressed with GFP-fused
CCN2, Rab14 CA and CCN2 also showed good colocalization as dots, but their distribution was more
widespread within the cytosol, as compared with those of wild-type Rab14 and CCN2 (Figure 3G).
In contrast, the coexpression of the dominant negative form Halo-fused Rab14S25N (Rab14DN) and
GFP-fused CCN2 also showed a dotted codistribution but was more concentrated in the perinuclear
area (Figure 3H). These results suggest that intracellular CCN2 was associated with Rab14 on vesicles
during their transport in cells.
2.4. Induction of ER and Golgi Stress by the Suppression of RAB14 or CCN2
To investigate the roles of intercellular CCN2 interacted with Rab14 in membrane trafficking
in chondrocytes, we decreased the expression of RAB14 mRNA using siRNA in HCS-2/8 cells and
monitored the gene expression of CCN2, ACAN, BIP, CHOP, and SIAT4A by qRT-PCR. The suppression of
RAB14 mRNA enhanced the expression of BIP, CHOP, and SIAT4A mRNA, suggesting that the inhibition
of membrane trafficking resulted in ER and Golgi stress. However, the inhibition of RAB14 mRNA did
not alter the gene expression of CCN2 and ACAN mRNA (Figure 4A). Similarly, we reduced the gene
expression of CCN2 and monitored the RAB14, ACAN, BIP, CHOP, and SIAT4A mRNA expression.
The expression of BIP, CHOP, and SIAT4A mRNA was significantly enhanced. The suppression of CCN2
did not change the RAB14 mRNA expression but decrease the ACAN mRNA expression (Figure 4B).
These data suggest that ER and Golgi stress were induced by the inhibition of membrane–vesicle
transfer via the suppression of CCN2 or Rab14.
2.5. Reduction in Aggrecan Accumulation in HCS-2/8 Cells by Rab14DN Overexpression
To study the effects of the interaction of CCN2 and Rab14 on the secretion of ECMs in chondrocytes,
we transfected HCS-2/8 cells with Rab14WT, Rab14CA, Rab14DN expression vectors, and Halo
expression vector (control) and monitored the accumulation of aggrecan, which is a major ECM in
cartilage, by toluidine blue (Figure 5A) or alcian blue (Figure 5C) staining. Rab14DN overexpression
in HCS-2/8 cells reduced the proteoglycan accumulation to less than 75% of that with Rab14WT
overexpression in both staining protocols (Figure 5B,D). Furthermore, when the expression of RAB14
mRNA was reduced using siRNA in HCS-2/8 cells, we monitored the accumulation of aggrecan.
The suppression of RAB14 mRNA decreased the accumulation to less than 87% of that with control
siRNA treatment in Alcian Blue staining (data not shown).
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Figure 4. Changes in the gene expression by the silencing of the RAB14 or CCN2 gene. The expression of
RAB14 or CCN2 mRNA was reduced using siRNA in HCS-2/8 cells, and the gene expression of RAB14,
CCN2, ACAN, BIP, CHOP and SIAT4A mRNA was monitored by qRT-PCR. The mRNA expression
profile of CCN2, ACAN, and stress marker genes in RAB14 knockdown cells (A). The mRNA expression
profile of RAB14, ACAN, and stress marker genes in CCN2 knockdown cells (B). The level of each
mRNA was standardized to that of GAPDH mRNA. The data are presented as the mean ± SD of
triplicate samples (t-test * P < 0.05, ** P < 0.01).
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intensity was quantified by measuring the absorbance at 635 or 605 nm with a spectrophotometer (B,D).
The data are presented as the mean ± SD of triplicate samples (t-test * P < 0.05, ** P < 0.01).
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3. Discussion
Rab GTPase is a master regulator that establishes secretory and endocytic pathways. The role of
Rab proteins is to recruit binding proteins called effectors, such as adaptor factors and motor proteins,
to facilitate downstream intracellular membrane trafficking [19]. Rab33B modulates autophagosome
formation through interaction with Atg16L [20]. Rab27A binds to Slp1/JFC1 in neutrophils and interacts
with Slp4/granuphilin in pancreatic β cells. These interactions are thought to promote the targeting
of the granules to the plasma membrane [21,22]. More than 60 Rab isoforms have been reported in
mammals, including humans and mice. There are several effector molecules for each Rab isoform,
and these effectors exhibit broad Rab binding specificity, binding to multiple Rab isoforms [23,24].
For example, the direct interaction of Rab14 with PKCι reportedly modulates the epithelial barrier
function through the regulation of claudin-2 [25], and its binding to KIF16B promotes the trafficking of
the FGFR-containing vesicles to the plasma membrane [16].
In the present study, we determined the expression of Rab14 in cartilage (Figure 1) and found
that Rab14 was a new interactive protein of CCN2, which is abundant in cartilage (Figures 2 and 3).
CCN2 is a secretory protein that accumulates at the cell surface and binds various extracellular matrix
components, such as fibronectin [8] and aggrecan [9]. CCN2 also interacts with several growth factors,
including TGF-β and BMP-4 [26], and thereby modulates their activities. Among CCN family members,
CCN3 directly interacts with CCN2 as a regulator of CCN2 in chondrocytes [10]. Although a few
other CCN member proteins are found in nuclei [11,27], CCN proteins, including CCN2, are generally
believed to manipulate extracellular signaling. In particular, there have been no reports showing that
CCN2 functions inside the cells. In the present study, we demonstrated for the first time the interactions
of Rab14 with CCN2 and provided evidence suggesting that the complex regulates intracellular
membrane trafficking in chondrocytes.
Using its four modules, CCN2 regulates the molecular network by manipulating these molecular
counterparts [28]. The specificity of interaction between Rab14 and CCN2 in the present study was
substantiated by the yeast two-hybrid assay, which revealed that Rab14 interacts to the IGFBP-like
domain of CCN2 (Figure 2A). Furthermore, the interaction between CCN2 and Rab14 in HCS-2/8 cells
was confirmed using in situ PLA (Figure 2B). The participation of Rab14 in trafficking between the Golgi
complex and early endosomes has been reported [15]; however, its specific role in membrane trafficking
is currently unknown. When Rab14WT was overexpressed without GFP-fused CCN2, Halo-tagged
Rab14 showed a diffuse cytosolic distribution in the cells (Figure 3E). When Rab14WT and CCN2 were
co-overexpressed, both molecules were almost completely colocalized and distributed as dots within
the cytosol (Figure 3F); these data indicate that CCN2 accelerates the dot-like association of Rab14.
Moreover, when Rab14CA and CCN2 were co-expressed, more widespread distribution of the dots
showing their co-localization was observed within the cytosol (Figure 3G). In contrast, when Rab14DN
and CCN2 were co-expressed, more concentrated dots showing their co-localization were observed
in the perinuclear area (Figure 3H). Taken together, these findings suggest that intracellular CCN2
enhances the accumulation of Rab14 on vesicles through the IGFBP-like domain of CCN2 during their
transport within the cytosol, and CCN2 may cooperatively regulate endocytotic trafficking with Rab14
as an effector protein.
The interactions between Rab GTPases and their effector proteins are critical events in vesicular
trafficking. Various lines of evidence suggest that defects in vesicular transport mechanisms lead to
ER stress [29], probably induced by the stagnation of proteins in the ER due to incompetent protein
trafficking. As shown in Figure 4, we observed that the silencing of RAB14 or CCN2 mRNA respectively
promoted the expression of ER or Golgi stress-related genes, such as BIP, CHOP, and SIAT4A, in
chondrocytic cells. The present findings suggest that a reduction in the activity of either Rab14 or CCN2
may cause ER or Golgi stress, accompanied by the failure of intracellular trafficking. Furthermore,
the ER stress derived from the stagnation of proteins within the cytosol may alter the secretion of
ECM in cartilage. Therefore, it is feasible that the overexpression of Rab14DN restricts vesicular
trafficking (Figure 3H). These data suggest that the cytosolic distribution of matrix-containing vesicles
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was inhibited by Rab14DN. The stagnation of vesicular trafficking would therefore enhance the basal
ER stress and influence the proteoglycan release and accumulation. We have reported that CCN2
stimulates the mRNA expression of aggrecan in chondrocytic cells [1–3] and siRNA against the CCN2
down-regulated mRNA expression of aggrecan in chondrocytic cells [30,31]. However, Rab14 is a
protein involved in intracellular membrane trafficking and not a signal inducer, so it is not surprising
that Rab14 siRNA had no effect on ACAN mRNA expression. Considering the role of Rab14, it is feasible
that Rab14 siRNA rather inhibits the intracellular transport of aggrecan, resulting in an accumulation
of aggrecan in the cytosol. For this reason, Rab14DN overexpression in chondrocytes reduce the
proteoglycan accumulation to a greater degree than Rab14WT overexpression (Figure 5). Concerning
the results that the CCN2-silincing caused ER and Golgi stress (Figure 4B), it is noteworthy that primary
chondrocytes from CCN2 deficient mice also showed reduced proteoglycan accumulation [32].
Based on the present findings, we propose a model for the regulation of vesicle trafficking by the
interaction between CCN2 and Rab14. Activated cytosolic Rab14 interacts with CCN2 as an effector
protein, and Rab14 associates with proteoglycan-containing vesicles. Consequently, this interaction
promotes vesicle trafficking. As a result, the Rab14-CCN2-associated vesicles promote the secretion
of proteoglycan into the extracellular space (Figure 6). Suppressing this trafficking induces ER and
Golgi stress through the failure of trafficking of proteoglycan-containing vesicles from the Golgi
complex. These results suggest that the interaction between CCN2 and Rab14 plays a critical role in
the chondrocytic function.
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4. Materials and Methods
4.1. Cell Culture
HCS-2/8, a human chondrosarcoma-derived cell line, MDA-MB-231, a human-breast-
cancer-derived cell line and COS7, a onk y ki n y cells were cultured in D lbecco’s Modified
Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), as d scribed
previously [12,18,33,34]. All cells were incubated under standard culture conditions (5% CO2
and 37 ◦C).
4.2. otal RNA Extraction, Reverse-Transcription, and qRT-PCR
Calvaria, brain, cartilage, heart, ki ney, liver, muscle, and spleen tissues fro four-day-old ice
were homogenized, and these total R As ere extracted using the easy i i it ( i , il ,
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Germany). The total RNA of the cell lines was also extracted by the same way. These RNAs were
reverse-transcribed with avian myeloblastosis virus reverse transcriptase (Takara Bio, Shiga, Japan) at
37 ◦C for 15 min and subjected to qRT-PCR (StepOnePlus; Applied Biosystems, Foster City, CA, USA)
using SYBR Green Realtime PCR Master Mix (Toyobo, Osaka, Japan). All operations were performed
according to each manufacturer’s instruction. The sequence of used primers is reported in Tables 1
and 2. The mRNA expression was normalized to the expression of the housekeeping gene Gapdh or
18S rRNA.
Table 1. Primer sequences for mouse tissues.
Gene Forward Reverse
Ccn2 ccacccgagttaccaatgac gtgcagccagaaagctca
Rab14 gcagatttgggatacagcaggg cagtgtttggattggtgagattcc
Gapdh * caatgaccccttcattgacc gacaagcttcccgttctcag
* It is common in mouse and human.
Table 2. Primer sequences for the human and monkey-derived cell line.
Gene Forward Reverse
CCN2 gcaggctagagaagcagagc atgtcttcatgctggtgcag
RAB14 agatttgggatacggcaggac cagtatttggattggtgagattcc
ACAN gaggagagaactggagaag gccgatagtggaatacaac
BIP gtttgctgaggaagacaaaaagctc cacttccatagagtttgctgataat
CHOP gtccagctgggagctggaag ctgactggaatctggagag
SIAT4A gataagatcctgatctaccacc ttgttctcccagtagtggtg
18S rRNA gcgaattcctgccagtagcatatgctg ggaagcttagaggagcgagcgaccaaagg
4.3. The Analysis of CCN2 Domain Interacting to Rab14
We performed yeast two-hybrid screening using a cDNA library derived from HCS-2/8 cells
as described previously [9,35]. For the investigation of the CCN2 domain interacting with Rab14,
the expression plasmid of full-length Rab14, which was expressed as a GAL4AD-fusion protein,
and plasmids including CCN2 fragments, which were co-expressed as GAL4BD-fusion proteins,
were used to transform AH109 yeast cells. The interaction was monitored by checking the growth of
yeasts on -Ade/-His/-Leu/-Trp synthetically defined medium. The primers used for the amplification of
the full-length and truncated forms of CCN2 are shown in Table 3.
Table 3. Primer sequences for the amplification of the full-length and truncated forms of CCN2.
CCN2 Fragment Forward Reverse
Full-length atccgaattccagaactgcagcgggccgtgccggtgcccg atacggatccctcatgccatgtctccgtacatcttcctgt
VWC-TSP1-CT atccgaattcgtgtgcaccgccaaagatggtgctccctgc atacggatccctcatgccatgtctccgtacatcttcctgt
TSP1-CT atccgaattcactatgattagagccaactgcctggtccaga atacggatccctcatgccatgtctccgtacatcttcctgt
CT atccgaattcaacattaagaagggcaaaaagtgcatccgt atacggatccctcatgccatgtctccgtacatcttcctgt
IGFBP atccgaattccagaactgcagcgggccgtgccggtgcccg atacggatccgagcaccatctttggcggtgcacacgccga
VWC atccgaattcgtgtgcaccgccaaagatggtgctccctgc atacggatccagttggctctaatcatagttgggtctgggc
TSP1 atccgaattcactatgattagagccaactgcctggtccaga atacggatccggatgcactttttgcccttcttaatgttct
4.4. In Situ Proximity Ligation Assay (PLA)
The CCN2 and Rab14 interaction in HCS-2/8 cells was examined using Duolink™ In Situ PLA
(Merck, Darmstadt, Germany). HCS-2/8 cells (200µL of a suspension with 1 × 105 cells/mL) in
DMEM/10%FBS were prepared on cover glasses and incubated for 24 h at 37 ◦C. The cells were fixed
with 4% PFA for 15 min. All remaining operations were performed according to manufacturer’s
instruction and a previous report [36]. Anti CTGF Module 3, Monoclonal Antibody (3-54) (Wako,
Osaka, Japan) and Anti-RAB14 antibody ab40938 (abcam, Cambridge, UK) were used as primary
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antibodies. The images were acquired using a fluorescence microscope (BZ-9000) (KEYENCE, Osaka,
Japan).
4.5. Expression Vectors
We prepared pEGFP/ccn2 vector, expressing CCN2 protein with GFP at the
C-terminus, by amplification of CCN2 cDNA with signal peptide using the primers
5′-cttcgaattcccatgaccgccagtatgggccccgtc-3′ and 5′-cggtggatcccgtgccatgtctccgtacatcttcctgta-3′ with
insertion into the EcoRI and BamHI sites of the pEGFP-N1 vector. We also prepared
pFlag-CMV/RAB14-HALO expressing Rab14WT protein with a Halo-tag at the C-terminus
of Rab14WT that was prepared by the amplification of RAB14 cDNA using the primers
5′-atccaagcttatggcaactgcaccatacaactactc-3′ and 5′-atacgaattcgcgcagccacagccttctctctg-3′ and by the
amplification of HALO [37]. The HALO fragment was cloned into the pFlag-CMV vector at the
EcoRI/BamHI sites, and the RAB14 fragment was cloned into the pFlag-CMV/HALO vector at the
HindIII/EcoRI sites. Rab14CA (Q70L) and Rab14DN (S25N) mutants were generated using a PCR
mutagenesis kit (TaKaRa Bio, Shiga, Japan) with the pFlag-CMV/RAB14-HALO as a template.
4.6. Western Blotting
The lysate of HCS-2/8, COS7, and MDA-MB-231 cells was analyzed by Western Blotting with an
antibody against CCN2 (R&D Systems, Minneapolis, MN, USA), Rab14 (Santa Cruz, Dallas, TX, USA),
and β-Actin (Sigma, St Louis, MO, USA), respectively. The COS7 cells that were transfected with
pEGFP⁄ccn2 or pFlag-CMV⁄RAB14-HALO (wt or mutants) were incubated for 48 h. The lysates were
harvested and analyzed by Western Blotting with an antibody against GFP or an antibody against
Rab14. Western Blot analysis was performed as described previously [5].
4.7. Fluorescence Imaging
We transiently transfected COS7 cells with different expression vectors and treated them with
the fluorescent ligand 2,6-dideoxy-4-thiomethyl-β-D-ribohexopyranoside (TMR), which recognize
HaloTag (Promega, Madison, US, USA), for 15 min at 37 ◦C, fixed them with 4% formaldehyde
(PFA)/phosphate-buffered saline (PBS) for 15 min at room temperature (RT), and then mounted them
on slides with Prolong Gold Mounting Medium containing 4′6-diamidino-2-phenylindole (DAPI)
nuclear stain (Life Technologies, Waltham, MA, USA). GFP-tagged proteins, Halo-tagged proteins,
and nuclei were directly monitored by fluorescence microscopy using an IX70 Microscope (Olympus
Corporation, Tokyo, Japan). The images were analyzed with the Axiovision software program
(Zeiss, Oberkochen, Germany).
4.8. Indirect Immunofluorescence and Fluorescence Deconvolution Microscopy
HCS-2/8 cells were fixed with 4% PFA/PBS for 15 min at RT, permeabilized with 0.25%
TritonX-100/PBS or not permeabilized for 8 min and then blocked with 5% skim milk in PBS for
1 h followed by incubation with primary antibodies for 90 min at RT. After being incubated with
secondary antibodies, images of the cells were obtained with an Olympus fluorescence microscope.
4.9. Small Interfering RNA (siRNA) Experiments
The expression of RAB14 and CCN2 was knocked down by RNA interference. MISSION®
siRNA directed against human Rab14 and CCN2 was purchased from Merck (Darmstadt, Germany).
MISSION® siRNA Universal Negative Control #1 was also purchased from Merck and used. HCS-2/8
cells were transfected with 30 nM of siRNA and seeded onto 6-well multiplates at 70–80% confluence.
At 24 h after transfection, total cellular RNA was harvested and evaluated for the expression of
each gene.
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4.10. Toluidine Blue and Alcian Blue Staining
HCS-2/8 cells in suspension, which transiently transfected with different expression vectors or
treated the siRNA, were seeded onto 6-well multiplates at 70–80% confluence and cultured for 7 days.
The culture medium was then removed, and the cells were washed with PBS. These cells were fixed
with paraformaldehyde (PFA) solution for 30 min at RT. The fixed cells were stained with 0.05%
toluidine blue solution or 1% alcian blue solution for 20 or 60 min at room temperature and then
washed three times with PBS. To quantify the staining intensity of the toluidine blue- and alcian
blue-stained matrix, the stained aggrecan was extracted with lysis buffer. The optical density of the
extracted dye was then measured at a wavelength of 635 or 605 nm.
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